RECHEM
Welcome to our website!|Hot Line: 86-21-31433387|E-mail: sales@rechemscience.com
Products Category
Contact Us
| Tel: | +86-21-31433387 |
| +86-15618786686 | |
| Email: | sales@rechemscience.com |
| info@rechemscience.com | |
| QQ: | 1369748377 |
| Skype: | sales@rechemscience.com |
| Cat.No. | Product name | Product Description |
| R10003 | Infigratinib (Synonyms: BGJ-398; NVP-BGJ398) | BGJ398 (NVP-BGJ398) is a potent and selective FGFR inhibitor for FGFR1/2/3 with |
| R10006 | Allitinib tosylate (Synonyms: AST-1306 (TsOH))/897383-62-9 Free base | AST-1306 is a novel irreversible inhibitor of EGFR and ErbB2 with IC50 of 0.5 nM |
| R10036 | XL880; Foretinib; GSK136308 | Foretinib (GSK1363089) is an ATP-competitive inhibitor of HGFR and VEGFR, mostly |
| R10037 | ANA12 | ANA-12 is a selective TrkB antagonist with Kd of 10 nM and 12 μM for the high an |
| R10042 | CO1686; Rociletinib | Rociletinib (CO-1686, AVL-301) is an irreversible, mutant-selective EGFR inhibit |
| R10054 | TAE684 | TAE684 (NVP-TAE684) is a potent and selective ALK inhibitor with IC50 of 3 nM in |
| R10058 | Masitinib | Masitinib is a novel inhibitor for Kit and PDGFRα/β with IC50 of 200 nM and 540 |
| R10061 | Nexavar; Bay 43-9006; Sorafenib | Sorafenib Tosylate is a multikinase inhibitor of Raf-1, B-Raf and VEGFR-2 with I |
| R10062 | SAR131675 | SAR131675 is a VEGFR3 inhibitor with IC50/Ki of 23 nM/12 nM in cell-free assays, |
| R10064 | Brivanib; BMS540215 | Brivanib is an ATP-competitive inhibitor against VEGFR2 with IC50 of 25 nM, mode |
| R10076 | Crizotinib (PF-02341066) | Crizotinib (PF-02341066) is a potent inhibitor of c-Met and ALK with IC50 of 11 |
| R10077 | AMG208 | AMG 208 is a highly selective c-Met inhibitor with IC50 of 9 nM. Phase 1. |
| R10078 | EMD1214063 | Tepotinib (EMD 1214063) is a potent and selective c-Met inhibitor with IC50 of 4 |
| R10087 | AZD9291 | Osimertinib (AZD9291) is an oral, irreversible, and mutant-selective EGFR inhibi |
| R10118 | Regorafenib; BAY73-4506; BAY734506 | Regorafenib (BAY 73-4506) is a multi-target inhibitor for VEGFR1, VEGFR2, VEGFR3 |
| R10126 | WZ4002 | WZ4002 is a novel, mutant-selective EGFR inhibitor for EGFR(L858R)/(T790M) with |
| R10127 | Linifanib (Synonyms: ABT-869; AL-39324) | Linifanib (ABT-869) is a novel, potent ATP-competitive VEGFR/PDGFR inhibitor for |
| R10138 | Tivozanib;AV-951; KRN951 | Tivozanib (AV-951) is a potent and selective VEGFR inhibitor for VEGFR1/2/3 with |
| R10143 | Cabozantinib (XL184; BMS-907351) | Cabozantinib (XL184, BMS-907351) is a potent VEGFR2 inhibitor with IC50 of 0.035 |
| R10150 | Ceritinib; LKD378 | Ceritinib (LDK378) is potent inhibitor against ALK with IC50 of 0.2 nM in cell-f |
| R10151 | E7080; Lenvatinib | Lenvatinib (E7080) is a multi-target inhibitor, mostly for VEGFR2(KDR)/VEGFR3(Fl |
| R10152 | Neratinib; HKI272 | Neratinib (HKI-272) is a highly selective HER2 and EGFR inhibitor with IC50 of 5 |
| R10156 | Nintedanib; BIBF1120 | Nintedanib (BIBF 1120) is a potent triple angiokinase inhibitor for VEGFR1/2/3, |
| R10192 | ZM323881HCl | ZM 323881 is a potent and selective VEGFR2 inhibitor with IC50 of <2 nM, almo |
| R10193 | ZM 306416 (Synonyms: CB 676475) | ZM 306416 is a VEGFR (Flt and KDR) inhibitor for VEGFR1 with IC50 of 0.33 μM, bu |
